News details

 
Information title

Experimental Agent Safe, May "Dissolve" Amyloid Plaques in Mild to Moderate AD

Published on Friday 08 August 2008 - 16:45

Summary :
Interim results of a phase 2 study testing an experimental monoclonal antibody that targets amyloid beta indicate it is safe, well tolerated, and may be able to "dissolve" amyloid plaques in the...
Read more

Information source

Medscape Medical News Headlines

http://www.medscape.com/welcome/news?src=rss

Website description
Latest medical news from Medscape

Articles published on this website : 0 / 7 days - 0 / 30 days

Low Early Cognitive Ability a Risk Factor for Long-Term Combination Alzheimer's Therapy Slows Decline Transcranial Stimulation Improves Memory in Alzheimer's Disease PET Scans May Detect Beta-Amyloid Deposition Linked to Low-Flow CSF Draining of No Benefit in Alzheimer

Other articles published on other websites on the same day

Scotty’s ashes go missing http://www.newspostonline.com/ Scotty's ashes go missing http://www.newspostonline.com/ Edward Rotchford: Reflecting on the Platform Draft http://www.huffingtonpost.com/ What do you want to hear more about or see implemented ? http://nextbigfuture.com/ Dawson County to Offer Maintain Your Brain® http://www.dawsontimes.com/ What’s In A Name? Maybe A Serious Side Effect http://www.pharmalot.com/ Dissents Of The Day http://andrewsullivan.theatlantic.com/ ProteoTech initiates Phase I human trial of Alzheimer's drug http://www.pharmaceutical-business-review.com/ 12th annual Memory Walk scheduled for September http://www.nwanews.com/ Hayward center for dementia patients provides respite for clients, families http://www.contracostatimes.com/